Vanda Ruling Opens Door For Contesting FDA Drug Denials
Chad Landmon, Claire Davies and Suzanne Bassett break down the Vanda Pharmaceuticals v. FDA decision, which may signal more aggressive legal challenges by drug companies fueled by the Supreme Court’s Loper Bright decision.
